We are live on ! Find out more
PIMJS

PKO Investment Management Joint-Stock Portfolio holdings

AUM $1.38B
1-Year Est. Return 59.54%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+59.54%
3 Year Est. Return
+124.73%
5 Year Est. Return
+130.21%
10 Year Est. Return
+742.49%
AUM
$811M
AUM Growth
+$1.28M
Cap. Flow
-$33.2M
Cap. Flow %
-4.1%
Top 10 Hldgs %
56.73%
Holding
168
New
4
Increased
40
Reduced
50
Closed
12

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$32M
2
MA icon
Mastercard
MA
+$3.53M
3
V icon
Visa
V
+$3.41M
4
NKE icon
Nike
NKE
+$2.83M
5
AMZN icon
Amazon
AMZN
+$2.62M

Sector Composition

Rank Sector Weight
1 Materials 17.01%
2 Technology 12.73%
3 Healthcare 7.5%
4 Consumer Discretionary 5.75%
5 Energy 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRI icon
101
Capri Holdings
CPRI
$1.77B
$1.06M 0.13%
25,000
WYNN icon
102
Wynn Resorts
WYNN
$10.6B
$1.05M 0.13%
11,000
CGAU
103
Centerra Gold
CGAU
$4.25B
$1.04M 0.13%
145,000
BMY icon
104
Bristol-Myers Squibb
BMY
$130B
$1.03M 0.13%
20,000
TPR icon
105
Tapestry
TPR
$31.1B
$1.03M 0.13%
22,000
NGD
106
DELISTED
New Gold Inc
NGD
$1.01M 0.13%
+350,000
New +$865K
ADM icon
107
Archer Daniels Midland
ADM
$38.4B
$1.01M 0.12%
16,900
-1,800
-10% -$110K
CRL icon
108
Charles River Laboratories
CRL
$13.6B
$985K 0.12%
+5,000
New +$1.04M
ISRG icon
109
Intuitive Surgical
ISRG
$142B
$983K 0.12%
2,000
NTR icon
110
Nutrien
NTR
$32.1B
$981K 0.12%
20,396
+2,500
+14% +$121K
FANG icon
111
Diamondback Energy
FANG
$56.2B
$948K 0.12%
5,500
CVE icon
112
Cenovus Energy
CVE
$55.6B
$929K 0.11%
55,500
SGI
113
Somnigroup International
SGI
$13.5B
$928K 0.11%
17,000
MAG
114
DELISTED
MAG Silver
MAG
$928K 0.11%
65,918
EW icon
115
Edwards Lifesciences
EW
$53.6B
$924K 0.11%
14,000
+8,000
+133% +$581K
DVN icon
116
Devon Energy
DVN
$49.3B
$886K 0.11%
22,661
DRD
117
DRDGold
DRD
$2.1B
$875K 0.11%
90,814
SSRM icon
118
SSR Mining
SSRM
$6.63B
$864K 0.11%
152,128
BMRN icon
119
BioMarin Pharmaceuticals
BMRN
$13.6B
$843K 0.1%
12,000
+6,000
+100% +$502K
REGN icon
120
Regeneron Pharmaceuticals
REGN
$82.2B
$841K 0.1%
800
+500
+167% +$556K
VRTX icon
121
Vertex Pharmaceuticals
VRTX
$133B
$837K 0.1%
1,800
+800
+80% +$384K
SILV
122
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$837K 0.1%
90,166
-97,000
-52% -$859K
NXE icon
123
NexGen Energy
NXE
$7.07B
$802K 0.1%
123,000
AG icon
124
First Majestic Silver
AG
$9.44B
$790K 0.1%
131,500
RL icon
125
Ralph Lauren
RL
$23.6B
$775K 0.1%
4,000

Similar funds

PKO Investment Management Joint-Stock's Q3 2024 Portfolio in Review

As of Q3 2024, PKO Investment Management Joint-Stock held 168 positions worth $811M, up 0.16% from $810M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

PKO Investment Management Joint-Stock withdrew a net $33.2M in Q3 2024, closing 12 positions and reducing 50 holdings. Its most notable exit was Mastercard, an estimated $3.53M position sold in full.

By sector, the portfolio is most concentrated in Materials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, PKO Investment Management Joint-Stock opened a new position in Take-Two Interactive worth $3.07M.

  • PKO Investment Management Joint-Stock's largest Q3 2024 buy was Take-Two Interactive: 20,000 shares worth $3.07M.
  • PKO Investment Management Joint-Stock added most to iShares Core S&P Small-Cap ETF in Q3 2024, an estimated $18.1M increase.
  • PKO Investment Management Joint-Stock's biggest Q3 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $32M.
  • PKO Investment Management Joint-Stock fully exited Mastercard in Q3 2024, selling an estimated $3.53M.
  • PKO Investment Management Joint-Stock's ten largest holdings make up 57% of its $811M portfolio in Q3 2024.
  • PKO Investment Management Joint-Stock opened 4 new positions and closed 12 in Q3 2024.
  • PKO Investment Management Joint-Stock's portfolio value rose 0.16% quarter-over-quarter to $811M.

Based on PKO Investment Management Joint-Stock's 13F filing for Q3 2024, filed 13 Mar 2025.